STUELPNAGEL JOHN R sold 5.4% of their position (20K shares) of 10X GENOMICS, INC. on the open market
Open‑market sale worth $1.16M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/13/2026ACC: 0001610717-26-000358
-20K
Net shares
Net seller
$1.16M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
20K disposed
Non-Derivative Transactions2
Class A Common Stock
Direct
Shares
−17K
Price / share
$57.58
Trade value
$978.88K
% of position
4.6%
8/11/2026
368.44K→351.44K
Class A Common Stock
Direct
Shares
−3K
Price / share
$58.73
Trade value
$176.18K
% of position
0.9%
8/11/2026
351.44K→348.44K
Total
Net shares
−20K
Net value
-$1.16M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 8/11/2026 | S · Sale | −17K | $57.58 | $978.88K | 4.6% | 368.44K | 351.44K |
| Class A Common Stock Direct | 8/11/2026 | S · Sale | −3K | $58.73 | $176.18K | 0.9% | 351.44K | 348.44K |
| Total | −20K | -$1.16M | ||||||
Derivative Transactions0
No derivative transactions reported